Investing.com - Financial Markets Worldwide
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Crescita Therapeutics Inc (CTX)

Toronto
Currency in CAD
0.5500
0.0000(0.00%)
Real-time Data
CTX Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Unlock Value
Day's Range
0.55000.5500
52 wk Range
0.36000.6900
Key Statistics
Edit
Bid/Ask
0.55 / 0.58
Prev. Close
0.55
Open
0.55
Day's Range
0.55-0.55
52 wk Range
0.36-0.69
Volume
-
Average Volume (3m)
25.34K
1-Year Change
41.03%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 9
Holds more cash than debt on its balance sheet
Unlock InvestingPro

Crescita Therapeutics Inc News & Analysis

Show more

Crescita Therapeutics Inc Company Profile

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations that can deliver actives into or through the skin. The company’s prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription portfolio offers dermocosmetic products, such as face creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud brand; and provides medical aesthetics under Pro-Derm and Alyria brands, for non-invasive and minimally invasive procedures or skincare treatments. In addition, it distributes NCTF Boost 135 HA, a skin revitalization solution; Obagi Medical products; and ART FILLER, hyaluronic acid-based dermal fillers. The company has a commercialization license agreement with Cantabria Labs Inc.; a development and commercialization license agreement with Taro Pharmaceuticals Inc.; and a distribution and promotion agreement with FILLMED. Crescita Therapeutics Inc. was founded in 2016 and is headquartered in Laval, Canada.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
0
Market
Canada

Compare CTX to Peers and Sector

Metrics to compare
CTX
Peers
Sector
Relationship
P/E Ratio
−3.9x−1.4x−0.6x
PEG Ratio
0.010.000.00
Price/Book
0.7x0.7x2.6x
Price / LTM Sales
0.6x1.5x3.2x
Upside (Analyst Target)
-42.9%46.2%
Fair Value Upside
Unlock13.3%7.0%Unlock

FAQ

What Is the Crescita Therapeutics (CTX) Stock Price Today?

The Crescita Therapeutics stock price today is 0.55

What Stock Exchange Does Crescita Therapeutics Trade On?

Crescita Therapeutics is listed and trades on the Toronto stock exchange.

What Is the Stock Symbol for Crescita Therapeutics?

The stock symbol for Crescita Therapeutics is "CTX."

What Is the Crescita Therapeutics Market Cap?

As of today, Crescita Therapeutics market cap is 10.55M.

What is Crescita Therapeutics Earnings Per Share?

The Crescita Therapeutics EPS is -0.14.

From a Technical Analysis Perspective, Is CTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.